Mumbai's slums may be reaching herd immunity, study finds


Some of the largest slums in Mumbai, India, may be nearing herd coronavirus immunity, a new serological survey found, Bloomberg reports.
The study tested 6,936 people across three suburbs in Mumbai — Dahisar, Chembur, and Matunga — and discovered that 57 percent of the subjects had coronavirus antibodies, a figure far higher than the 21 percent found in New York City in April and 14 percent in Stockholm, Sweden, in May. Per Bloomberg, epidemiologists generally believe a population must reach infection levels of 60 percent to achieve herd immunity, so the study indicates the neighborhoods are pretty much there. The survey appears to go hand-in-hand with a steep decline in cases in the slums in recent weeks, despite India having the world's fastest growth in infections overall.
Social distancing is a challenge in the crowded Mumbai neighborhoods, which seemingly makes them well-suited for the virus' spread, and the study suggests that it did so widely. Fortunately, the population in the slums is young and more likely to avoid severe cases of COVID-19. That, coupled with successful government containment measures that helped catch cases early and ensure high quality care, have kept the fatality low in the slums, even if many infections went undetected, Bloomberg notes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It's encouraging that some of Mumbai's slums may be closing in on herd immunity without experiencing a high death rate, but the jury is still out on how long immunity lasts. It's also worth noting antibody rates were not nearly as high in other parts of Mumbai, where social distancing is more feasible. Read more at Bloomberg.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Scottish hospitality shines at these 7 hotels
The Week Recommends Sleep well at these lovely inns across Scotland
By Catherine Garcia, The Week US Published
-
Scientists invent a solid carbon-negative building material
Under the radar Building CO2 into the buildings
By Devika Rao, The Week US Published
-
Crossword: April 1, 2025
The Week's daily crossword
By The Week Staff Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published